₹1852.2
+2.67% today
· 30d +9.15%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for AUROPHARMA. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-03-31
REVENUE
₹8853 Cr
+5.62% YoY
NET PROFIT
₹921 Cr
+1.99% YoY
OPM
20.84%
-1.78pp YoY
EPS
₹15.86
PE 26.47
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-17.6%, h2=-17.2%, h3=-14.6% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
ML Forward Growth Predictions 🔒
72
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
STRONG
100
Valuation
REASONABLE
60
Growth
STEADY
67
Profitability
DECENT
68
Technicals
NEUTRAL
60
Risk
LOW
80
Key Stats
TTM PE
26.47
P/B
2.67
52W HIGH
₹1856.1
OFF HIGH
-0.21%
DIV YIELD
0.75%
MKT CAP
₹106842 Cr
◉ Active Signals
MACDBullish23.4188
RSI(14)Bearish74.9
Near 52W HighBullish-0.21
Street Consensus
27 analysts₹1856.04
mean target
Low ₹1270.0Now ₹1852.2High ₹2195.0
⧉ Strategy Fit 🔒